2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective
ACS Nano · 2025
DOI: 10.1021/acsnano.5c04323 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Munusamy Shanmugam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Tsing Hua University, Hsinchu 30013, Taiwan R.O.C. Hauptthemen laut MEDLINE: Photochemotherapy, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Tsing Hua University, Hsinchu 30013, Taiwan R.O.C.
- Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan R.O.C.
ORCID-Profile: Kuo Chu Hwang
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Shanmugam, M., Chiang, C. S., & Hwang, K. C. (2025). 2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective. ACS Nano. https://doi.org/10.1021/acsnano.5c04323
Vancouver
Shanmugam M, Chiang CS, Hwang KC. 2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective. ACS Nano. 2025. doi:10.1021/acsnano.5c04323
BibTeX
@article{Shanmugam2025,
author = {Shanmugam, Munusamy and Chiang, Chi-Shiun and Hwang, Kuo Chu},
title = {2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c04323}
}
EUVIMED